Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Non Operating Income (2016)

Historic Non Operating Income for Sanofi (SNY) over the last 8 years, with Q4 2016 value amounting to -$135.0 million.

  • Sanofi's Non Operating Income rose 6768.23% to -$135.0 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$799.5 million, marking a year-over-year decrease of 413.55%. This contributed to the annual value of -$138.4 million for FY2016, which is 6805.64% up from last year.
  • Sanofi's Non Operating Income amounted to -$135.0 million in Q4 2016, which was up 6768.23% from -$130.2 million recorded in Q1 2016.
  • Sanofi's Non Operating Income's 5-year high stood at -$104.1 million during Q1 2014, with a 5-year trough of -$417.6 million in Q4 2015.
  • Its 5-year average for Non Operating Income is -$170.9 million, with a median of -$151.6 million in 2013.
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 14213.12% in 2015, then skyrocketed by 6768.23% in 2016.
  • Sanofi's Non Operating Income (Quarter) stood at -$256.8 million in 2012, then skyrocketed by 45.4% to -$140.2 million in 2013, then dropped by 23.03% to -$172.5 million in 2014, then crashed by 142.13% to -$417.6 million in 2015, then soared by 67.68% to -$135.0 million in 2016.
  • Its last three reported values are -$135.0 million in Q4 2016, -$130.2 million for Q1 2016, and -$417.6 million during Q4 2015.